Member Login

feed image
Teva and Medicis settle dispute regarding acne treatment - MarketWatch
More info...

Visit Bulgaria
Teva and Medicis settle dispute regarding acne treatment
MarketWatch
By Robert Daniel , , ) the Scottsdale, Ariz., drugmaker focused on skin and aesthetic conditions, settled their litigation regarding Medicis's Solodyn extended-release prescription acne treatment. In statements late on Wednesday, the companies said ...
FDA denies Medicis petition on acne drug patent Reuters
Medicis Pharmaceutical (MRX) NewsBite - MRX Jumps on Acne Drug ... Market Intelligence Center
Teva wins FDA approval for acne treatment Globes
Arizona Republic - Reuters

all 103 news articles


Warner Chilcott sues Impax over acne drug Doryx - The Associated Press


Washington Times
Warner Chilcott sues Impax over acne drug Doryx
The Associated Press
NEW YORK (AP) Warner Chilcott Ltd. said Thursday it is suing Impax Laboratories Inc., accusing Impax of infringing a patent supporting 150 milligram tablets of Warner Chilcott's acne medication Doryx. Bermuda-based Warner Chilcott said it believes ...
Warner Chilcott Sues Impax Again In Doryx IP Spat IP Law360 (subscription)
Impax Lab Confirms ANDA Filing for Doryx Generic Tablets - Update RTT News
all 109 news articles


Drug Maker Stiefel Labs Considers Selling Itself - Wall Street Journal


Drug Maker Stiefel Labs Considers Selling Itself
Wall Street Journal
Stiefel, which makes anti-itch creams, acne treatments and other dermatological remedies, is hoping to fetch somewhere in the range of $3 billion to $4 billion, according to these people. A spokeswoman for Stiefel said the company's board has not ...
Stiefel Labs Looks for Spot on Pharma Takeover List Wall Street Journal Blogs
Drug giants eyeing US skincare firm Stiefel: report Reuters
Big Pharmas eye Stiefel Labs buy FiercePharma
FierceBiotech - RTT News
all 87 news articles
 
< Prev   Next >

Latest News